| 000 | 01873 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515223151.0 | ||
| 264 | 0 | _c20100617 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1532-1827 | ||
| 024 | 7 |
_a10.1038/sj.bjc.6605686 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFareed, K R | |
| 245 | 0 | 0 |
_aTumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cMay 2010 |
||
| 300 |
_a1600-7 p. _bdigital |
||
| 500 | _aPublication Type: Evaluation Study; Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdiagnosis |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aBiomarkers, Pharmacological _xanalysis |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xmetabolism |
| 650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
| 650 | 0 | 4 | _aCell Proliferation |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xmetabolism |
| 650 | 0 | 4 |
_aEndonucleases _xmetabolism |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 |
_aPlatinum Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aStomach Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTissue Array Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Burden _xphysiology |
| 700 | 1 | _aAl-Attar, A | |
| 700 | 1 | _aSoomro, I N | |
| 700 | 1 | _aKaye, P V | |
| 700 | 1 | _aPatel, J | |
| 700 | 1 | _aLobo, D N | |
| 700 | 1 | _aParsons, S L | |
| 700 | 1 | _aMadhusudan, S | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 102 _gno. 11 _gp. 1600-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6605686 _zAvailable from publisher's website |
| 999 |
_c19815947 _d19815947 |
||